Treatment of breast cancer brain metastases

被引:11
|
作者
Hofer, Silvia [1 ]
Pestalozzi, Bernhard C. [1 ]
机构
[1] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland
关键词
Brain metastasis; Breast cancer; Genetic subtype; Prognosis; Local treatment; Systemic treatment; RADIATION-THERAPY; STEREOTACTIC RADIOSURGERY; SINGLE METASTASES; PHASE-II; TRASTUZUMAB; RADIOTHERAPY; SURVIVAL; LAPATINIB; TRIAL; RISK;
D O I
10.1016/j.ejphar.2012.11.068
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breast cancer represents the second most frequent cause of brain metastases. Treatment planning should consider several tumor and patient factors to estimate prognosis based on the Karnolsky Performance Status (RE'S), age, extent of extra-cerebral disease as well as genetic subtype. When systemic disease is under control patients with up to three metastases qualify for local therapy, such as surgical excision or stereotactic radiotherapy. After the local treatment the addition of whole brain radiation therapy may be postponed until disease progression in the brain is observed and overall survival will not be compromised. Asymptomatic brain metastases may be first approached with a systemic treatment to which the primacy tumor is considered to be sensitive. (C) 2013 Elsevier B.V. All rights reserved,
引用
收藏
页码:84 / 87
页数:4
相关论文
共 50 条
  • [1] Breast cancer brain metastases - A 12 year review of treatment outcomes
    De Ieso, P. B.
    Schick, U.
    Rosenfelder, N.
    Mohammed, K.
    Ross, G. M.
    BREAST, 2015, 24 (04) : 426 - 433
  • [2] Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases
    Fabregat-Franco, C.
    Stradella, A.
    Navarro, V.
    Linares, J.
    Galdeano, M.
    Recalde, S.
    Velasco, R.
    Simo, M.
    Fernadez, A.
    Venthecourt, A. C.
    Falo, C.
    Vazquez, S.
    Bergamino, M.
    Villanueva, R.
    Pernas, S.
    Gil-Gil, M. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (09) : 1761 - 1768
  • [3] Brain metastases from breast cancer
    Tallet, A.
    CANCER RADIOTHERAPIE, 2013, 17 (07): : 708 - 714
  • [4] Evolving treatment strategies of brain metastases from breast cancer: current status and future direction
    Kim, Jae Sik
    Kim, In Ah
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [5] Systemic treatment of brain metastases from breast cancer
    Taillibert, S.
    Conforti, R.
    Bonneterre, J.
    Bachelot, T.
    Le Rhun, E.
    Bernard-Marty, C.
    CANCER RADIOTHERAPIE, 2015, 19 (01): : 36 - 42
  • [6] Current Treatment Options for Breast Cancer Brain Metastases
    Raghunath, Arrvind
    Desai, Kunal
    Ahluwalia, Manmeet S.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (03)
  • [7] Treatment and Prognosis of Breast Cancer Patients with Brain Metastases According to Intrinsic Subtype
    Kuba, Sayaka
    Ishida, Mayumi
    Nakamura, Yoshiaki
    Yamanouchi, Kosho
    Minami, Shigeki
    Taguchi, Kenichi
    Eguchi, Susumu
    Ohno, Shinji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (11) : 1025 - 1031
  • [8] Brain metastases in breast cancer
    Sim, Hao-Wen
    Morris, Patrick G.
    Patil, Sujata
    Khasraw, Mustafa
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (02) : 173 - 183
  • [9] Multidisciplinary Management of Breast Cancer Brain Metastases
    Zagar, Timothy M.
    Van Swearingen, Amanda E. D.
    Kaidar-Person, Orit
    Ewend, Matthew G.
    Anders, Carey K.
    ONCOLOGY-NEW YORK, 2016, 30 (10): : 923 - 933
  • [10] Brain metastases in breast cancer: analysis of the role of HER2 status and treatment in the outcome of 94 patients
    Fokas, Emmanouil
    Henzel, Martin
    Hamm, Klaus
    Grund, Steffen
    Engenhart-Cabillic, Rita
    TUMORI, 2012, 98 (06) : 768 - 774